ABSTRACT. We examined the frequency of RsaI polymorphism of the ERβ gene in 54 patients diagnosed with endometriosis and 46 controls. Peripheral blood was collected from women undergoing laparoscopy with a confirmed diagnosis of endometriosis. Polymorphisms of the ERβ gene and p53 were assessed by PCR and analyzed on 2% agarose gel stained with ethidium bromide. The AG polymorphism genotype frequency in patients with endometriosis was 59.3%, with 40.7% GG. In the control group, the frequency of AG was 6.5%, with 93.5% GG. The frequency of heterozygous AG was nine times higher in patients with endometriosis than in the control group (P < 0.0001).
INTRODUCTION
Endometriosis is an estrogen-dependent disease. This hormone is involved in growth, differentiation and functioning of reproductive tissues, including ovaries, uterus, mammary glands, and vagina (Zhao et al., 2000) . Its action is mediated by intracellular receptors, which, with the binding of ligands, are translocated to the nucleus, where it activates gene transcription. There are two subtypes of estrogen receptors (ERα and ERβ); they exhibit distinct cell and tissue differentiation distributions (Sneige et al., 2006) .
The ERβ gene has been mapped and is located in the long arm of chromosome 14 at locus 2 among subloci 23 and 24 (14q22-24) (Enmark et al., 1997) . The first studies were conducted on this gene after the initial characterization performed by Tsukamoto et al. (1998) of highly polymorphic dinucleotide repeats in exon 5 of the human ERβ gene in the Japanese population. Five different sequences of variants, including two mutations and three polymorphisms, were detected by systematic mutation screening. The first was silent transition T1421C in exon 7; the second was silent transition G1082A in the binding domain of exon 5, and the third was single nucleotide polymorphism (SNP) A1730G in the 3'-untranslated region of exon 8 (Nakata et al., 2004) .
More recently, five new polymorphisms were identified in an African population. Three of them (C143T in exon 1, A566T in exon 2, and T1100G in exon 5) are silent polymorphisms, while the other two exchanged the amino acid sequence of ERβ. These include A105G SNP in exon 1, changing the isoleucine to valine and a T1057G SNP in exon 5 requires the substitution of valine for glycine at position 320 in helix 4 in the binding domain (Galliano, 2009) .
The study of estrogen receptors and their correlation with endometriosis could help explain the genetic etiology, collaborating in diagnosis and treatment. To this end, we examined the frequency of the RsaI polymorphism of the ERβ gene in patients with endometriosis and without symptoms.
MATERIAL AND METHODS
We collected 100 samples of peripheral blood from: 1) 54 women with endometriosis with a mean age of 32.5 years, and 2) 46 women without clinical disease with a mean age of 37.4 years. All patients had the diagnosis confirmed by laparoscopy and were classified according to the American Fertility Society -1985, and revised in 1996 by the American Society for Reproductive Medicine as Grade I (minimum), Grade II (mild), Grade III (moderate), and Grade IV (severe). The patients answered a questionnaire about personal data and social habits.
DNA extraction from peripheral blood was performed in accordance with the manufacturer of the GFX TM kit (Amersham Pharmacia Biotech, USA) protocol for whole blood, following the guidelines of the technique described by Miller (1988) . The DNA integrity was certified by electrophoresis on 2% agarose gel stained with ethidium bromide (0.5 mg/mL) and visualized with a Video Documentation System VDS ® (Amersham Biosciences, USA).
Polymerase chain reaction (PCR)
We performed allele-specific PCRs to detect variants of the RsaI polymorphism of the ERβ gene, using specific primers for the polymorphic variant "A" and the wild-type "G"; each reaction was carried out with control primers. The primers and expected size of the frag-ments were as suggested by Aschim et al. (2005) . The control had 409 bp and the variants A and G had 127 bp: RsaI Fw 5' ACT TGC CAT TCT GTC TCT ACA 3', RsaI Control Rev 5' CAC AGG ACC CTG AAT CTC 3', RsaI A Rev 5' AGC TCT CCA AGA GCC GT 3', Rev G RsaI 5' AGC TCT CCA AGA GCC GC 3'. The PCR conditions were established to generate both a control fragment and a shorter one, allele-specific band in the presence of the variant, and only the control fragment in the absence of the variant. The possible outcomes of the genotypes of RsaI polymorphism of the ERβ gene using the primers proposed by Aschim et al. (2005) are AA, AG or GG (Figure 1 ). The PCR product was separated by electrophoresis on 2% agarose gel stained with ethidium bromide (10 mg/mL) in Tris-borate EDTA (TBE) at 1X solution. The gel was subjected to a constant electric field of 10 V/cm for 1 h and 30 min. Then, the gels were stained with ethidium bromide at 5 g/mL for 20 min. The visual record of the gel was made with the aid of a video-documentation system (Image Master ® VDS -Amersham Pharmacia Biotech, USA). The reactions were run in duplicate.
RESULTS
The genotype frequencies found in patients with endometriosis (N = 54) were 0% of the AA genotype, 59.3% of the AG genotype and 40.7% of the GG genotype. Among the control patients (N = 46) the frequencies were 0% of the AA genotype, 6.5% of the AG genotype and 93.5% of the GG genotype. The frequency of heterozygous genotype AG of the RsaI polymorphism of the ERβ gene in patients with endometriosis was approximately nine times higher than in control patients (P < 0.001; Table 1 ).
The group of patients with endometriosis was divided into two subgroups of fertile and infertile. The distribution of allelic frequency of fertile patients (N = 25) was 17 AG and 8 GG. Among the infertile patients (N = 27), there were 15 AG and 12 GG. The AA genotype frequency was not found in any group. The AG allele frequency in the fertile patients with endometriosis was approximately 10.5 times higher than in the control group, and the allelic frequency of the AG genotype in the infertile women was 8.5 times higher compared to controls (P < 0.0001 for both; Table 2 ). The P value was calculated by the χ 2 test. The P value was calculated by the χ 2 test. 
DISCUSSION
We found the allelic frequency of RsaI polymorphism of the ERβ gene in AG to be about nine times higher in patients with endometriosis compared to controls, similar to what The P value was calculated by the χ 2 test. was found by Sundarrajan et al. (2001) . They found that in Chinese women with ovulatory dysfunction, the allele frequency of RsaI polymorphism of the ERβ gene was significantly higher than in controls. However, they found the homozygous AA genotype in patients with ovulatory dysfunction and not in the control group, different from our findings. Renner et al. (2006) reported in their studies that endometriosis is an estrogen-dependent pathology; it is possible that genetic variation in the mediation of the estrogen pathway allows for potentiation of estrogen, facilitating the initiation and growth of endometriosis. We found that the frequency of the RsaI polymorphism of the ERβ gene was higher in fertile women with endometriosis, indicating more of this hormone.
However, when we compared fertile and infertile subgroups, we found no significant differences. Hapangama et al. (2008) claimed that endometriosis is associated with decreased expression of endometrial ERβ and is associated with cell proliferation and up-regulation of telomerase. They indicated that telomerase specifically correlates with cell proliferation and that many cancers express high levels of telomerase. Tempfer et al. (2009) reported that the ERβ gene is associated with increased risk of stage IV endometriosis in Japanese women, while we found polymorphism in all stages of classification of endometriosis of the patients. Hsieh and Lin (2006) concluded that there is an association between endometriosis and p53 polymorphisms. The arginine allele in homozygosis at codon 72 is associated with low susceptibility to developing endometriosis. The proline allele in double dose (Pro/Pro) or only one allele (Pro/Arg) is related to higher susceptibility. In a study by Chang et al. (2002) , the proline allele was found to be related to a two to three times higher incidence of endometriosis. We also found that the genotype frequency of p53 polymorphism is correlated with the RsaI polymorphism of gene ERβ and that there is a higher frequency in the genotypes Arg/Pro + Pro/Pro and AG in patients with endometriosis than in the control group. Endometriosis is enigmatic because its etiology is not fully understood. We examined the molecular basis of endometriosis and its correlation with the RsaI polymorphism of the estrogen receptor beta gene. Further prospective studies should examine the molecular events in gene ERβ in endometriosis, exploring various methodologies such as endometrial biopsies, as well as quantitative analysis of mRNA, with emphasis in the cyclical hormonal levels, correlating with different degrees of classification of endometriosis.
